Vicarious Surgical annual r&d spending
2020
2021
2022
2023
2024
2025
Vicarious Surgical R&D Spending Growth & History (RBOT)
Vicarious Surgical's r&d spending was $33.6M for fiscal 2025.
View full Vicarious Surgical company overviewVicarious Surgical annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $33.6M | −$6.6M | −16.32% |
| 2024 | 2024-12-31 | $40.2M | −$7.4M | −15.60% |
| 2023 | 2023-12-31 | $47.6M | $3.7M | +8.38% |
| 2022 | 2022-12-31 | $43.9M | $21.8M | +99.01% |
| 2021 | 2021-12-31 | $22.1M | $12.3M | +125.18% |
| 2020 | 2020-12-31 | $9.8M | — | — |
Vicarious Surgical quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $5.0M | −$4.4M | −46.48% |
| Q4 2025 | 2025-12-31 | $7.1M | −$1.3M | −15.60% |
| Q3 2025 | 2025-09-30 | $8.0M | −$2.8M | −25.99% |
| Q2 2025 | 2025-06-30 | $9.1M | −$1.9M | −17.15% |
| Q1 2025 | 2025-03-31 | $9.4M | −$553,000 | −5.55% |
| Q4 2024 | 2024-12-31 | $8.5M | −$5,000 | −0.06% |
| Q3 2024 | 2024-09-30 | $10.8M | −$2.2M | −17.18% |
| Q2 2024 | 2024-06-30 | $10.9M | −$1.8M | −14.08% |
| Q1 2024 | 2024-03-31 | $10.0M | −$3.4M | −25.37% |
| Q4 2023 | 2023-12-31 | $8.5M | −$3.4M | −28.70% |
| Q3 2023 | 2023-09-30 | $13.0M | $920,000 | +7.59% |
| Q2 2023 | 2023-06-30 | $12.7M | $2.7M | +26.44% |
| Q1 2023 | 2023-03-31 | $13.4M | $3.5M | +35.62% |
| Q4 2022 | 2022-12-31 | $11.9M | $2.6M | +28.33% |
| Q3 2022 | 2022-09-30 | $12.1M | $6.9M | +133.57% |
| Q2 2022 | 2022-06-30 | $10.1M | $6.0M | +150.87% |
| Q1 2022 | 2022-03-31 | $9.8M | $6.2M | +173.02% |
| Q4 2021 | 2021-12-31 | $9.3M | — | — |
| Q3 2021 | 2021-09-30 | $5.2M | $2.7M | +107.23% |
| Q2 2021 | 2021-06-30 | $4.0M | — | — |
| Q1 2021 | 2021-03-31 | $3.6M | — | — |
| Q3 2020 | 2020-09-30 | $2.5M | — | — |
Vicarious Surgical r&d spending trends
Over the last five fiscal years, Vicarious Surgical's r&d spending increased from $9.8M to $33.6M, a change of $23.8M. The latest reported quarter, Q1 2026, shows $5.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicarious Surgical source filings ↗